SC 13G/A: Kiniksa Pharmaceuticals International, plc

AI Summary

SC 13G/A filing by Kiniksa Pharmaceuticals International, plc.

Risk Assessment

Risk Level: low

Key Financial Figures

• $0.000273235 — e of Issuer) Class A Ordinary Shares, $0.000273235 nominal value (Title of Class of Secur

Filing Documents

• p24-3179sc13ga.htm (SC 13G/A) — 55KB
• 0000902664-24-006617.txt ( ) — 57KB

(a)

Item 1(a). NAME OF ISSUER The name of the issuer is Kiniksa Pharmaceuticals International, plc (f/k/a Kiniksa Pharmaceuticals, Ltd.)(the " Company ").

(b)

Item 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES The Company's principal executive office is located at 23 Old Bond Street, Floor 3, London, WIS 4PZ, England, United Kingdom.

(a)

Item 2(a). NAME OF PERSON FILING This statement is filed by: (i) HHLR Advisors, Ltd., an exempted Cayman Islands company (" HHLR ") and (ii) Hillhouse Investment Management, Ltd., an exempted Cayman Islands company (" HIM "). The foregoing persons are hereinafter sometimes each referred to as a " Reporting Person " and collectively referred to as the " Reporting Persons ." HHLR acts as the sole investment manager of HHLR Fund, L.P. (" HHLR Fund "). HIM acts as the sole management company of Hillhouse Fund III, L.P. (" HFIII "). HH RSV-XVII Holdings Limited (" HH RSV XVII ") is wholly owned by HFIII. HIM is hereby deemed to be the beneficial owner of, and to control the voting and investment power of, the Class A Ordinary Shares (as defined in Item 2(d) below) held by HH RSV XVII. HHLR and HIM are under common control and share certain policies, personnel and resources. Accordingly, each of HHLR and HIM reports on this Schedule 13G/A that it has shared voting and dispositive power of the Class A Ordinary Shares beneficially owned by each of HHLR and HIM.

(b)

Item 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE The address of the business office of each of the Reporting Persons is Office #122, Windward 3 Building, Regatta Office Park, West Bay Road, Grand Cayman, Cayman Islands, KY1-9006.

(c)

Item 2(c). CITIZENSHIP Cayman Islands

(d)

Item 2(d). TITLE OF CLASS OF SECURITIES Class A Ordinary Shares, $0.000273235 nominal value (the " Class A Ordinary Shares ").

(e)

Item 2(e). CUSIP NUMBER G52694109 Item 3. IF THIS STATEMENT IS FILED PURSUANT TO Rules 13d-1(b), OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A: (a) ¨ Broker or dealer registered under Section 15 of the Act; (b) ¨ Bank as defined in Section 3(a)(6) of the Act; (c) ¨ Insurance company as defined in Section 3(a)(19) of the Act; (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940; (e) ¨ An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); CUSIP No. G52694109 13G/A Page 5 of 7 Pages (f) ¨ An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) ¨ A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) ¨ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; (j) ¨ A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J); (k) ¨ Group, in accordance with Rule 13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution: __________________________________ Item 4. OWNERSHIP The percentage set forth in this Schedule13G/A was calculated based upon an aggregate of 40,608,972 Class A Ordinary Shares outstanding as of July 19, 2024, as reported in the Company's Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2024, filed with the Securities and Exchange Commission on July 25, 2024. The information required by Items 4(a) - (c) is set forth in Rows 5 - 11 of the cover page for each of the Reporting Persons (and the footnotes thereto) and is incorporated herein by reference. Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS If this statement is being filed to report the fac

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. DATE: November 14, 2024 HHLR Advisors, LTD. /s/ Audrey Woon Name:Audrey Woon Title:Chief Compliance Officer Hillhouse Investment Management, Ltd. /s/ Audrey Woon Name:Audrey Woon Title:Chief Compliance Officer